Diabetes is a disease in which levels of blood glucose are too high. Rates of type 2 diabetes are higher in people living with HIV than in the general population.

Diabetes: latest news

Diabetes resources

  • Other health issues

    As you get older, it’s even more important to regularly attend clinic appointments and stay in touch with your healthcare providers. Your HIV clinic appointments will include...

    From: Booklets

    Information level Level 2
  • Other tests

    Blood pressure is the force that the beating heart causes in the arteries, veins, and blood vessels that carry blood around the body. Blood pressure is measured...

    From: Booklets

    Information level Level 2
  • Type 2 diabetes and HIV

    Changes to your lifestyle can reduce your risk of diabetes.Diabetes requires frequent monitoring and can have serious consequences if left untreated. Rates of diabetes are higher in people...

    From: Factsheets

    Information level Level 2
  • HIV treatment, metabolic changes and ageing

    Smoking, lack of exercise, eating a lot of fatty foods and drinking a lot of alcohol can cause changes to blood fats and to the way your...

    From: Booklets

    Information level Level 2
  • Conditions related to HIV treatment, metabolic changes and ageing

    Lipodystrophy is a condition which causes changes in body shape and involves fat loss or fat gain in certain parts of the body. Long-term use of some older anti-HIV...

    From: Booklets

    Information level Level 2

Diabetes features

Diabetes news from aidsmap

More news

Diabetes news selected from other sources

  • Individualized lifestyle intervention may reduce type 2 diabetes risk in HIV

    For adults with HIV, a lifestyle intervention focused on energy restriction, weight reduction and improved diet may be an effective way to decrease type 2 diabetes risk, according to findings published in Diabetic Medicine.

    14 March 2019 | Healio
  • Switching to Raltegravir or Dolutegravir Improves Leptin and Insulin in HIV

    Switching to either raltegravir or dolutegravir from a ritonavir-boosted protease inhibitor during combination antiretroviral therapy (ART) has been associated with improved serum leptin levels and homeostasis model assessment of insulin resistance (HOMA) index scores in people with HIV infection, according to a study recently published in the Journal of Antimicrobial Chemotherapy.

    27 February 2019 | Infectious Disease Advisor
  • As Waistlines Increase, Diabetes Sets In In Tanzania

    Fast-changing lifestyle coupled with improving household economies have propelled the rate of obesity which culminates in diabetes at an alarming rate in Tanzania, with urban areas leading the tally. Medical experts say the metabolic disease is a looming health hazard in the country.

    16 January 2019 | Health Policy Watch
  • Rising Incidence of Diabetes in Adults With HIV on Antiretroviral Therapy

    The burden of diabetes and prediabetes is rapidly increasing in people living with HIV on antiretroviral therapy (ART), according to research published in Epidemiology.

    27 March 2018 | Infectious Disease Advisor
  • Long-Term Treated HIV No Defense Against Diabetes Risk

    It has long been thought that the heightened risk of diabetes among people living with HIV was mostly due to early-generation antiretroviral drugs that raised glucose levels. But a longitudinal Australian study published in the Feb. 20, 2018, issue of AIDS found that, even in the modern treatment era, HIV-positive men who have sex with men (MSM) developed diabetes at an extremely high rate.

    06 March 2018 | The Body Pro
  • Older antiretroviral regimens raise diabetes risk in HIV-positive adults

    HIV-positive adults who initiated older formulations of antiretroviral therapy are more likely to develop type 2 diabetes than patients who initiated therapy between 2010 and 2015, according to study findings reported in BMJ Open Diabetes Research.

    05 December 2017 | Healio
  • Many adults with diabetes delay insulin therapy

    Three in ten adults with type 2 diabetes who need to start taking insulin to lower their blood sugar don’t begin treatment when their doctors tell them to, a recent study suggests.

    02 October 2017 | Reuters
  • Widely used diabetes test may not be suitable for Africans

    People of African descent may mistakenly get the all-clear from a widely used type 2 diabetes test called HbA1c, according to an international study. The findings have important implications as they suggest that using this test as the sole means to diagnose diabetes would do harm, said University of the Witwatersrand endocrinologist Alisha Wade.

    14 September 2017 | Medical Brief
  • HCV eradication in HIV coinfected patients linked to reduced diabetes, chronic renal failure

    Eradication of hepatitis C virus infection among patients coinfected with HIV was associated with reductions in diabetes and chronic renal failure in addition to reduced mortality, HIV progression and liver-related events, according to the results of a Spanish cohort study. These findings led investigators to conclude that HIV coinfected patients should receive HCV therapy regardless of their fibrosis stage.

    31 January 2017 | Healio
  • People with HIV more likely to develop diabetes, study finds

    A new study suggests the diabetes prevalence is much higher among HIV-positive individuals than the general population, even when obesity is not present.

    31 January 2017 | HIV / AIDS News From Medical News Today
More news
Tell us why you visited aidsmap today
minimise

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?

close

Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email info@nam.org.uk.

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.